(Q54333340)

27 May 2018

title

The HPV test in cervical screening: a brave new world? (English)

1 reference

27 May 2018

author name string

M S Desai

series ordinal

1

1 reference

27 May 2018

Heather A Cubie

series ordinal

2

1 reference

27 May 2018

publication date

1 February 2005

1 reference

27 May 2018

published in

Cytopathology

1 reference

27 May 2018

volume

16

1 reference

27 May 2018

issue

1

1 reference

27 May 2018

page(s)

3-6

1 reference

27 May 2018

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Management of women who test positive for high-risk types of human papillomavirus: the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

HPV testing in primary screening of older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2005.00237.X

10.1111/J.1365-2303.2005.00237.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018